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The dynamic approach to venous
disease—following in the footsteps of Gunnar
Bauer and Robert Kistner
Bo Eklöf, MD, PhD, Lund, SwedenIt is a privilege for me to address you during this
Seventeenth Annual Meeting of the American Venous Fo-
rum (AVF). It was a great moment of my life when you
chose me as your president-elect in Cancun, Mexico, in
2003, and I was escorted to the podium by Anthony
Comerota and Robert Kistner. The last year has meant
intense work with our excellent board, particularly monthly
conference calls across the Atlantic with the executive com-
mittee, including Thomas Wakefield, Frank Padberg,
Joann Lohr, Joseph Caprini, and Robin Hoyle. Last Sep-
tember at the retreat with the board in Washington, DC,
the potential new directions for AVF were discussed:
● develop a new format for the annual meeting to ac-
commodate the educational needs of vascular surgeons
in training,
● work with the program directors in writing a venous
curriculum as part of the certificate in vascular training,
● establish a venous screening program with the Ameri-
can Vascular Association, and
● build partnerships with other venous societies such as
the American College of Phlebology, the European
Venous Forum, and the Venous Forum of the Royal
Society of Medicine.
I am living in southern Sweden on the shore of Öre-
sund, the busy waterway between Denmark and Sweden.
To the right, I see Helsingör in Denmark with Hamlet’s
castle, Kronborg, and to the left, in the middle of the
sound, the island of Ven. Ven is Swedish for vein, so every
morning when I open my eyes, I am reminded of veins.
The island of Ven is famous for being the home of
Tycho Brahe (1546-1601), the Danish nobleman and as-
tronomer who was fighting other stargazers like Coperni-
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doi:10.1016/j.jvs.2005.04.032cus, Kepler, and Galilei about basic laws of the universe,
such as whether the sun was circling the earth or vice versa.
Sir Isaac Newton (1642-1727), the English father of mod-
ern science, was referring to Tycho Brahe and his colleagues
in his famous expression “If I have seen further (than
others), it is by standing on the shoulders of giants.”
Stimulated by the island of Ven, I would like to present
two pioneers whose groundbreaking work is the founda-
tion of modern phlebology and an inspiration for all of us
involved in the management of venous disease—Gunnar
Bauer and Robert Kistner—proving my point of “one giant
standing on the shoulder of another.”
GUNNAR BAUER (1895-1970)
Gunnar Bauer, the father of Swedish phlebology, at-
tended medical school at the University of Lund and Karo-
linska Institute in Stockholm and graduated in 1922. He
started his surgical career with Clarence Craaford, the
Swedish pioneer in cardiothoracic surgery at Sabbatsberg
Hospital in Stockholm. During 1926-1933, he continued
his surgical training at the hospital in Malmö, where he also
defended his 1,000-page PhD thesis on peritonitis after
appendicitis. After a few years in Sveg, a tiny hospital in
northern Sweden, he moved to Mariestad in southern
Sweden in 1937, where he stayed until his retirement in
1960. He was the only physician at this small hospital for
many years.
The lack of assistance and inspiration from other col-
leagues, in addition to their criticism, makes his contribu-
tions even more impressive. Despite working at this remote
hospital, his collaboration with Craaford’s group in Stock-
holm continued. Bauer had an early interest in venous
thromboembolism. Two medical milestone events paved
the way for his future: the unique contributions of Jorpes’
purification of heparin in 1935 and Dos Santos’ develop-
ment of ascending venography in 1938.
Bauer’s contributions include his venographic descrip-
tion of
● the normal venous system of the leg,
● acute thrombosis of the leg, post-thrombotic (second-ary) deep venous incompetence, and
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His treatment contributions include
● treatment of acute thromboembolism with heparin,
and
● treatment of idiopathic (primary) and post-thrombotic
(secondary) deep venous incompetence with resection
of the popliteal vein.
The normal venous system. The same year as Dos
Santos published his paper, Bauer perfected the technique
of venography and started to use it in his clinical practice.
The venographic image of the normal venous system was
practically unknown, but Bauer outlined the typical dupli-
cated veins following the three arteries in the calf with their
densely arranged valves, and the solitary popliteal and fem-
oral veins with fewer valves.
Acute thrombosis. Before Bauer’s publications it was
commonly supposed that the thrombotic process started in
the femoral or pelvic veins and then extended retrogradely
into the deep leg veins. Bauer was able to demonstrate that
this was not true and that:
● a thrombosis in the calf veins is more common than
previously believed,
● the thrombotic process starts in the calf veins in most
cases,
● the acute thrombosis can be accurately diagnosed in its
earliest stage by venography, and
● the evolving thrombotic process and the final post-
thrombotic state can be studied by venography.
When Bauer’s first publication appeared in 19401 it
described discoveries of the utmost importance, not only
for scientific enlightenment but also for clinical practice.
Bauer particularly emphasized the importance of detecting
the early, easily overlooked clinical signs and how these
signs corresponded to the venographic findings. In a 10-
year follow-up of 100 patients with deep vein thrombosis
(DVT) who did not receive any treatment,2 he found that
all had swelling of the leg, 90% had skin induration, and
80% had venous ulcers with severe pain and a risk of fatal
infections. He found that if the valves in the popliteal vein
were preserved, the post-thrombotic syndrome developed
in very few patients, and he envisioned:
Is it not possible to intervene in the course of develop-
ments and prevent the popliteal vein from being invaded
by the thrombus? With venography the thrombus can be
diagnosed while it is still localized to the calf veins. Why
cannot some means be developed by which to prevent its
further spread upwards? If this could be done, it would
also mean that the late results of thrombosis could be
radically changed. A prophylactic against the post-throm-
botic disease would have been found.
The post-thrombotic (secondary) deep venous in-
competence after acute DVT. Already in 1866, John Gay
had pointed out that skin changes and leg ulcers were, in his
experience, invariably associated with post-thrombotic dis-ease of the deep veins. This concept was reiterated by
Homans, who believed that post-thrombotic damage to
the deep veins was the probable cause of leg ulcers and that
so-called venous stasis was the crucial factor. Before 1940,
the sequelae of acute thrombosis were relatively unknown.
Chronic edema, eczema, and ulceration were thought to be
caused by varicose vein disease.
Clinical and venographic studies convinced Bauer that
the post-thrombotic syndrome developed because the ini-
tially effective subcutaneous venous collaterals dilate and
become varicose as a result of overloading. He changed his
initial belief that the deep veins remained occluded after
DVT because of findings obtained with a new technique:
descending transfemoral venography in the upright posi-
tion, which showed that recanalization of the deep veins
was the rule and permanent occlusion the exception, and
also that the valves were destroyed during this process.
Bauer appears to have been the first to state that the
destruction of the deep vein valves was the reason for the
development of post-thrombotic disease. He was con-
vinced that the deleterious change was the conversion of
the valve-bearing popliteal and femoral veins into a valve-
less tube, resulting in a dysfunctional calf muscle pump.
Idiopathic (primary) deep venous incompetence.
Bauer agreed with Homans that in almost every case of
severe chronic venous insufficiency with pain, swelling and
ulceration, the cause was “venous stasis” resulting from
valvular incompetence of the femoral vein. On descending
venography in 55 patients with deep reflux,3 he surprisingly
noted that in 30 limbs it was “not caused by thrombosis, a
condition which seems to be very little known,” both then,
in1948 as well as now, in 2005. In the absence of the exact
knowledge of the etiology, he termed this condition idio-
pathic:
● no history of DVT;
● hereditary disposition for varicose veins;
● female predominance, but not related to pregnancies;
● clinical picture the same as in post-thrombotic pa-
tients;
● venographic picture markedly different from post-
thrombotic patients;
● the femoral vein was generous with uniform width;
● abundant valve formations seen;
● contrast often followed down to the ankle;
● macroscopically normal-looking vein;
● microscopically thickening of the intima of the venous
wall with hyaline fibrosis; and
● marked fibrosis in the media, with splitting of the
elastic elements and atrophy of the muscular layer.
Bauer’s interpretation was that there was a loss of
elasticity in the vein wall leading to dilatation and subse-
quent incompetence of the valve. A vicious circle is started
with reflux leading to further dilatation. He regretted his
own lack of knowledge about the microscopic state of the
valves.
Treatment of acute thrombosis with heparin.
Heparin was discovered in 1916 by Jay McLean, a second-
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Jorpes at Karolinska Institute in Stockholm defined the
chemical structure and purified heparin in 1935. Simulta-
neously, Jorpes and Craaford in Stockholm and Murray and
Best in Toronto tested heparin in thromboembolic disease.
Based on a large controlled study in Stockholm on 627
patients operated on between 1937 and 1940, Craaford4
showed that prophylactically given intravenous heparin
starting immediately after surgery with a 7-day duration
totally eliminated thromboembolic complications and
mortality after major surgery. Aware of this study, Bauer in
Mariestad, who had started to use venography to diagnose
DVT, now introduced the epoch-making treatment of
venous thromboembolism (VTE) with heparin.
Jorpes, in his 1946 book on heparin, acknowledged
Bauer’s role in the treatment of VTE: “The most valuable
contribution to the development of this question has been
made by Gunnar Bauer.”5 Michael DeBakey from Houston
confirmed Bauer’s role in a personal conversation in 2003
in Lund, Sweden.
Bauer’s principles were early diagnosis confirmed by
venography, intravenous heparin treatment, early mobili-
zation, and compression bandaging. At a meeting in Stock-
holm on December 1, 1940, at the same time as Craaford
presented his findings of prophylaxis, Bauer reported his
early results on 21 patients with calf vein thrombosis treated
with this model compared with 32 patients with calf vein
thrombosis before he had access to heparin (Table)6 In the
heparin treated group, none had proximal extension com-
pared with 75% in the nontreated group; none had clinical
pulmonary embolism compared with 34%; none developed
contralateral DVT compared with 31%; and the bed rest
was 7 days compared with 43 days.
These results were sensationally good, and Bauer ex-
plained that was due to the ability to detect the thrombosis
in its earliest state by venography, thus allowing for the
administration of heparin earlier than was previously possi-
ble. Bauer continued to treat his patients according to his
principle, and in 1964, he published 937 cases of throm-
bosis with only seven fatal pulmonary embolisms (1%).7
Treatment of the idiopathic (primary) and post-
thrombotic (secondary) deep venous incompetence
with resection of the popliteal vein. Having identified
deep reflux as the main culprit in severe chronic venous
insufficiency—be it of primary or secondary etiology and
believing in the crucial role of popliteal vein reflux—Bauer
took the next step in treatment and recommended resec-
tion of the popliteal vein to stop the reflux into the calf
veins.3 Homans and Linton in Boston had advocated fem-
oral vein ligation for similar reasons. However, Bauer ar-
gued that the ligation of the femoral vein distal to the
confluence of the profunda was inadequate because it al-
lowed reflux through the profunda vein to communicate
with the distal femoral vein, creating another valveless axial
reflux stem to the calf.
Popliteal vein resection turned out to have low morbid-
ity. The patients wore a compression bandage for at least 2
months, sometimes much longer. Bauer reported markedimprovement in all patients. The aching, bursting pain was
relieved at once, and the ulcers generally healed in a shorter
time than after conservative treatment. He published500
cases and performed 1,000 popliteal vein resections in
Mariestad. His credo, though, was that the best way to
control the post-thrombotic syndrome was to prevent its
development by treating the acute thrombosis immediately
and aggressively, hoping to prevent the development of a
valveless femoral tube.
Gunnar Bauer criticized. Naturally, the Swedish ra-
diologists criticized this Swedish surgeon (not an unusual
phenomenon) for his venographic technique with the pa-
tient supine, where he may have misinterpreted filling
defects as thrombus and consequently obtained excellent
results with heparin therapy. Many also maintained that the
excellent initial results of popliteal vein resection in patients
with severe chronic venous insufficiency could be related to
the efficient postoperative compression treatment and care-
ful wound care. Thirty-eight of Bauer’s original patients
were followed up 20 years later by Hallböök and Lindha-
gen.8 All but two patients had a relapse of their previous
problems, and 50% had recurrent venous ulcers. Repeat
venography showed that refluxing collaterals had devel-
oped, bypassing the resected popliteal vein. In a commen-
tary, John Bergan wrote “. . .the last outpost of vascular
ligation finally surrendering.”
Gunnar Bauer, the Swedish pioneer. Gunnar Bauer,
the first modern phlebologist, introduced proper diagnosis
and directed treatment for acute and chronic venous dis-
ease. He described the venographic findings of the normal
and thrombosed veins in the leg and how fresh thrombi
progressed from the calf veins into the proximal leg veins.
He elucidated the recanalization process of the occluded
deep veins and proved the connection between the post-
thrombotic reflux due to destroyed venous valves and
chronic venous insufficiency. He was the first to describe
idiopathic (primary) deep venous incompetence, a shoulder
for Robert Kistner to stand on, introducing venous valve
reconstructions. Bauer revolutionized the management of
patients with acute DVT by introducing venography for
early diagnosis and intravenous heparin combined with
early mobilization and the compression bandage for treat-
Early results of Bauer’s study in patients with calf vein
thrombosis treated with heparin*
No heparin (%) Heparin
No. of cases 32 21
No. with proximal extension 24 (75) 0
Clinical PE 11 (34) 0
No. of cases with
contralateral leg DVT
10 (31) 0
Mortality VTE 2 (6) 0
Bedrest, days 43 7
PE, Pulmonary embolism;DVT, deep vein thrombosis;VTE, venous throm-
boembolism.
*Table modified from ref 6.ment.
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treatment marks a turning point in phlebology. Gunnar
Bauer’s contribution was significant, and he worked hard as
a missionary to promote his gospel: he published 100
papers in the phlebologic field and gave numerous lectures
in Sweden as well as abroad. With Knut Haeger, he created
Societas Phlebologica Scandinavica in 1963, where until his
death in 1970, he continued to inspire research and educa-
tion in the true spirit of the American Venous Forum.
Through his son, Hans Bauer, I got a copy of all of
Gunnar Bauer’s publications, which I brought with me to
Kuwait with the idea to write a biography of his pioneering
works. Unfortunately, I lost all of my documents during
the occupation of Kuwait by Saddam Hussein in 1990. The
Iraqi dictator apparently had a special interest in venous
disease.
ROBERT KISTNER
Standing on the shoulders of Gunnar Bauer is another
giant, Robert Kistner, the pioneer for venous reconstruc-
tive surgery, who got his medical degree from the medical
school at St Louis University in 1954. After surgical resi-
dency in St Louis, he passed his surgical board in 1961 and
completed his vascular surgery training with a fellowship at
the Cleveland Clinic in 1965. Since 1966, Robert Kistner
has been working at Straub Clinic and Hospital in Hono-
lulu, Hawaii, where all his pioneering work on venous
disease has taken place:
● internal valve repair,9
● descending venography to classify the severity of re-
flux,10
● transposition of the incompetent deep vein into a valve
bearing segment,11
● external valve repair,12 and
● endophlebectomy.13
I have had the privilege to know Robert Kistner since
1982, when he was the first visiting professor during my
tenure as professor and chair of surgery at the University of
Kuwait (1981-1990). When Saddam Hussein ended my
Middle East career in 1990, Bob offered me an opportunity
to join him in Hawaii, where I started at Straub Clinic and
Hospital in February 1991, which gave me more than 12
years of collaboration in this venous Mecca.
Internal valve repair. At the postgraduate course for
the AVF in February 2004, Kistner gave a presentation on
“From Serendipity to Practicality: Fundamental Questions
Generated by the First Successful Valve Repair in 1968.”
He described his first patient, who suffered swelling and
pain of the extremity within 30 minutes of getting out of
bed and was disabled from work. He had apparently had
DVT 2 years before. An ascending venogram showed pa-
tency of the deep veins, incompetent perforator veins of the
calf, and evidence of a recanalized femoral vein. A descend-
ing venogram showed severe reflux in the femoral vein
extending into the crural veins, with no obstructive ele-
ments. Surgical repair of the proximal femoral valve was
performed 4 days after calf perforator interruptions and wasfollowed by immediate relief of pain and swelling and
subsequent return to work. A postoperative venography
proved the valve competent and the deep veins patent. The
patient was followed for 12 years, without recurrence of
symptoms. Kistner wrote:
Were it not for a number of fortunate events that com-
bined to make the first case successful, it is likely that the
subsequent vigorous attempts to do more cases would
have been blunted or discarded. The case began with the
good fortune that this man had a repairable valve high in
the femoral vein combined with more distal deep vein
thrombosis. The valve was entirely normal except for a
floppy cusp when the vein was opened (subsequently
termed primary valve disease). There were no visible signs
that the venous thrombosis had extended to the level of
this valve. The distal femoral vein and the popliteal vein
were patent, but were interpreted as being post-throm-
botic. A whole series of additional fortunate events oc-
curred as the diagnostic workup and the newly devised
surgical repair were carried out, and the ultimate fortu-
nate event was that the procedure was uncomplicated and
dramatically successful in relieving the patient’s disability.
Kistner’s 1968 report9 of the first valve repair came 20
years after Bauer’s description of idiopathic valvular incom-
petency. However, the control of reflux by Bauer’s destruc-
tive resection of the popliteal vein had now been replaced
by Kistner’s reconstructive repair of the floppy valve. After
the success of this first case, Kistner realized the need for an
accurate workup of patients with severe chronic venous
disorders (CVD) to separate reflux problems from obstruc-
tive problems, to localize the sites of potentially repairable
reflux, and to identify whether the reflux was due to “pri-
mary” valve cusp stretching or to post-thrombotic scarring
and destruction of the cusp.
Descending venography to classify the severity of
reflux. Bauer had developed the technique of descending
venography in the standing position. He had shown the
difference between post-thrombotic deep venous reflux
with valve destruction and idiopathic valve incompetence
with uniformly widened femoral vein, abundant valve for-
mations, and reflux, often to the ankle. This technique was
further refined by Kistner, who developed the Straub tech-
nique,10 where descending venography is performed on a
fluoroscopic table capable of a 60° tilt. The procedure is
videotaped to provide a permanent record and for later
review.
A catheter is percutaneously introduced from the con-
tralateral common femoral vein and passed across the infe-
rior vena cava confluence to study the affected extremity.
This allows selective catheterization of the major veins of
interest. The reflux is classified into 4 grades, where grade 1
is a wisp of reflux and grade 4 is cascading reflux into calf.
The purpose of descending venography is to establish
the ability of proximal valves to close and prevent reflux. If
no valves are competent, each of the refluxing valves is
clearly seen and the operability of the valve is established.
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secondary valvular incompetence.
Reconstruction for deep venous reflux. In Kistner’s
long-term results (4 to 21 years of follow-up),14 three
groups could be distinguished: primary valvular incompe-
tence (PVI) with 70% good-to-excellent clinical out-
come; secondary (post-thrombotic) valvular incompetence
(SVI), where mainly transposition was performed with
40% positive outcome; and finally, the combination PVI/
SVI where60% good-to-excellent clinical outcomes were
achieved.
Kistner stimulated many followers who have reported
their own series: DePalma, United States; Eriksson, Swe-
den; Gloviczki, United States; Hoshino, Japan; Lurie, Rus-
sia; O’Donnell, United States; Perrin, France; Raju, United
States; Sottiurai, United States; Taheri, United States; and
Tripathi, India. In 2004, Perrin15 published an excellent
review on venous reconstruction for deep venous reflux.
Reconstruction for deep venous obstruction. The
combination of proximal, mainly iliac vein obstruction and
distal deep venous reflux leads to the highest degree of
venous hypertension and most severe postthrombotic syn-
drome. The original bypass procedures— femorofemoral
for iliac vein occlusion and saphenopopliteal for femoral
vein occlusion—are today almost obsolete. Iliocaval ob-
structions are currently treated by angioplasty and stenting.
Raju and Neglén16 have performed 700 procedures with
a cumulative secondary patency rate of 90%. Kistner’s
group13 has shown that surgical endophlebectomy of post-
thrombotic veins is feasible as an adjunct to deep venous
reconstruction, particularly to improve the inflow before
iliac vein angioplasty.
The surgical release of synechiae, septae, and endolu-
minal masses significantly increases diameter, compliance,
and flow in treated vein segments as observed by duplex
scans. As Bauer had already stated, the best way to avoid
iliac vein obstruction is aggressive treatment of the acute
thrombotic episode with early thrombus removal, which
today is possible by catheter-directed thrombolysis, percu-
taneous thrombectomy, or open thrombectomy.
Robert Kistner, the American pioneer. Kistner, like
Bauer, based his development in the management of ve-
nous disease on proper diagnosis followed by precise treat-
ment. At the Straub Clinic and Hospital in Honolulu,
Hawaii he created a true venous center for the management
of acute and chronic venous disease, where the Straub
Foundation was the base for research and education. It has
had a venous research fellowship program since 1990, with
the following fellows: Elna Masuda, Howard Wong, Dean
Sato, and Nahidh Hassaniya, United States; Danian Yang,
China; Berndt Arfvidsson, Sweden; Gudmundur Daniels-
son, Iceland; Tomohiro Ogawa, Japan; Alessandra Pug-
gioni, Italy; and Bert van Gent, The Netherlands.
After the introduction of the three reconstructive pro-
cedures—internal and external repair of primary valvular
incompetency and transposition in secondary valvular in-
competency—the need for improved diagnostic tools was
evident. There was no standardization of the noninvasivetests in different vascular laboratories and no accurate clas-
sification, so that badly needed interinstitutional trials were
difficult to conduct. Kistner realized this need, and he was
one of the initiators of the 1994 CEAP consensus meeting
on Maui under the AVF umbrella. Kistner is currently
active with Fedor Lurie in evaluating the function of the
venous valve in health and disease.17-20 Like Bauer, Kistner
is a missionary travelling the world, promoting his gospel
that “specific diagnosis and specific treatment in CVD is a
concept whose time has now come.”21
Aggressive treatment of iliofemoral venous
thrombosis. Others have followed in the footsteps of
Gunnar Bauer and Robert Kistner. Bauer established the
importance of early diagnosis of DVT using venography,
instituting heparin treatment, and early ambulation to
avoid the post-thrombotic syndrome. Kistner demon-
strated that the results after venous reconstructive surgery
were superior in patients with primary deep valvular incom-
petence compared with patients with secondary (post-
thrombotic) incompetence. It therefore seems logical to
assume that the initial removal of the thrombus should be
most advantageous.
The importance of early thrombus removal has recently
been further emphasized by studies on the inflammatory
response to DVT. Wakefield and his group22 in Ann Arbor
have shown that the leucocyte adhesion molecule P-selec-
tin activates the leucocytes migrating into the venous wall,
creating an inflammation that destroys the venous wall and
the valves. Harris and his group23 from Stanford showed in
another experimental model that if the thrombus was re-
moved, the inflammatory changes were reversible. The
importance of the proximal obstruction for the develop-
ment of distal valvular incompetence has been carefully
studied by Strandness and his group in Seattle. In a series of
articles, they have shown that
● from 20% to 50% of initially uninvolved distal veins
became incompetent by 2 years24;
● the combination of reflux and obstruction, as opposed
to either alone, correlated with the severity of symp-
toms and was present in 55% of symptomatic pa-
tients25;
● 25% of all venous segments developed reflux in time, of
which 32% were documented to not have been previ-
ously involved with thrombosis26; and, finally
● in a study of the posterior tibial veins located below a
popliteal segment involved with thrombosis, 55% of
the distal veins became incompetent if the segment
remained obstructed, compared with 7.5% of those
below a popliteal vein that recanalized.27
These changes in the distal veins occur early enough
that they can’t be blamed on proximal valvular reflux,
although this also comes into play with time. Thus, it would
appear that the early relief of obstructing thrombus by
thrombolysis or thrombectomy should prevent more ex-
tensive post-thrombotic sequelae, if only by protecting the
distal veins against progressive valvular incompetence. This
is a pivotal point that has not been well recognized, not
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results of thrombolysis and thrombectomy, where critics
have largely ignored the restoration of proximal patency
while focusing on the presence or absence of valve reflux.
The conclusions from the studies cited above are clear: early
removal of the proximal thrombus conveys significant ben-
efits, and the earlier the removal, the better the outcome.
In this address, I will focus on the development of
venous thrombectomy, which is a valid alternative if cath-
eter-directed thrombolysis or percutaneous mechanical
thrombectomy fail or are contraindicated.
The first thrombectomy for iliofemoral DVT was per-
formed by Läwen28 in Germany in 1937. In 1940, Homans
discussed indications for thrombectomy with hepariniza-
tion, with or without ligation of the femoral vein.29 The
modern era for thrombectomy in the United States started
with Mahorner’s 1954 article “New Management for
Thrombosis of Deep Veins of Extremities”30 in which he
advocated for thrombectomy and regional heparinization
and presented five of six patients with excellent clinical
results. The enthusiastic wave created by the Mahorner
blues, and especially boosted by the Haller and Abrams31
reports in 1963, was efficiently quelled by Lansing and
Davies32 in 1968 with their 5-year follow-up of the Haller
and Abrams patients.
One of the most enthusiastic groups came from Strong
Memorial Hospital in Rochester, NY. I had the privilege to
spend a year as research fellow there in 1968 to 1969. It was
an excellent academic vascular center under the leadership
of Charles Rob. For many years, it was also a center for
venous disease, with pioneers such as James Adams, An-
drew Dale, James DeWeese, Walter Pories, and Seymour
Schwartz.33
I returned to the University of Lund, Sweden ready to
perform venous thrombectomies. Inspired by a report from
Jean Kunlin34 on the use of a temporary arteriovenous
(TAV) fistula to improve outcomes of venous reconstruc-
tive surgery and the application by Jörg Vollmar and Hen-
ning Loeprecht of this technique, the first iliofemoral ve-
nous thrombectomy with a TAV fistula was performed in
1974. My personal experience of this surgical procedure
now comprises200 patients: 70 in Lund, Sweden (1974-
1978); 31 in Helsingborg, Sweden (1978-1981); 102 in
Kuwait (1981-1990); and 10 in Hawaii (1991-2003).
Four PhD theses were partly based on this development
at the University of Lund.35-38 We performed a prospec-
tive, randomized study comparing thrombectomy plus
TAV fistula with conservative treatment in patients with
acute iliofemoral DVT, with follow-up after 6 months, and
5 and 10 years.39-41 We found a significantly better patency
of the iliac vein in the surgical group, which also showed
better competency of the deep veins.
Continuous improvement of the surgical technique has
taken place. During my 9 years at the University of Kuwait,
we were consulted on400 patients with acute iliofemoral
DVT, mainly young women during or after pregnancy.
Together with the Indian coagulationist Dipika Mohanty,
we started a prospective study on coagulation and fibrino-lytic factors in women with normal pregnancies and DVT.
We had protocols for 100 individuals in our computer
system, which was taken to Iraq at the time of invasion
1990, another proof of Saddam Hussein’s interest in ve-
nous disease.
The Czech interventional cardiologist Jiri Endrys, who
worked in our team, developed a percutaneous technique
to occlude the TAV fistula via the untouched contralateral
femoral artery by placement of inflatable balloons into the
fistula.42 Simultaneously, venography was used to study the
proximal thrombectomized iliac vein, and in case of ob-
struction, an angioplasty could be performed, which today
would be combined with stenting.
Drs Al Hassan, Christenson, Nazzal, and Neglén stud-
ied the effect of extension of the iliac clot into the inferior
vena cava (IVC) in 52 patients.43 They showed that all
patients with failed removal of the IVC clot developed
DVT in the contralateral leg compared with one patient
(7%) in the group with successful IVC thrombectomy.
The procedure of thrombectomy plus TAV fistula pro-
vides the vascular surgeon with an interesting combination
of specific open surgical technique with modern catheter-
based adjunctive techniques to improve the outcome:
● Fogarty balloon catheter;
● intraoperative venogram, angioscopy, or intravascular
ultrasound scan to check for iliac vein compression or
remaining thrombus;
● intraoperative angioplasty and stenting;
● intraoperative regional thrombolysis;
● insertion of a temporary IVC filter;
● arteriovenography to check TAV fistula and thrombec-
tomized iliac vein postop; and
● percutaneous closure of TAV fistula.
The role of American Venous Forum to support the
dynamic development of the venous disease. The
Tower of Babel was created by the descendants of Noah to
reach the sky, but the Lord punished the arrogant people by
splitting their common language and spreading them from
Babylon all over the world (Genesis 11:1-9). Saddam tried
to rebuild the tower, which was supposed to be a large cube
with each side 92 m long, and you all know how the wrath
of God came down on him.
AVF has tried to tear down this Tower of Babel and
create the CEAP classification as a common language for
chronic venous disorders, which previously suffered from a
lack of precision in description. This deficiency led to
conflicting reports in studies of the management of CVD at
a time when new modalities were being offered to improve
treatment for simple as well as more complicated venous
diseases. It was believed that these conflicts could be re-
solved by precise diagnosis and classification of the under-
lying venous problem.
Although there have been several classifications of
CVD in the past—the most well known is the Widmer
classification—none provided the completeness and objec-
tivity needed for scientific accuracy. At the Fifth Annual
Meeting of the AVF in Orlando, Fla, in 1993, John Porter
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CHAT for carotid artery disease in developing a classifica-
tion system for CVD.
After a year of intense discussions, a consensus confer-
ence was held at the Sixth Annual Meeting of AVF on
Maui, Hawaii, in February 1994, where an international ad
hoc committee, chaired by Andrew Nicolaides with repre-
sentatives from Australia, Europe, and the United States,
developed the first CEAP consensus document.44 The
classification was based on clinical manifestations (C), eti-
ologic factors (E), anatomic distribution of disease (A), and
the underlying pathophysiologic findings (P), thus the
name CEAP. I tried to get “history” in as one factor, but
the committee did not like a CHEAP classification. The
CEAP consensus statement was published in 26 journals
and books and translated into nine languages (reflecting
the Babel effect). Today, most articles about CVD use all or
portions of CEAP.
Diagnosis and treatment of CVD is developing rapidly,
and the need for an update was obvious when Peter Glov-
iczki in April 2002 appointed an ad hoc committee on
CEAP to review the classification and make recommenda-
tions for change by 2004, 10 years after its introduction. An
international ad hoc committee was also established to
assure continued utilization. The committees held four
meetings to revise the document, which was published in
the Journal of Vascular Surgery in December 2004.45 The
recommended changes include:
● refinements of several definitions used in describing
CEAP,
● refinement of the C-classes of CEAP,
● addition of the prescript “n” (no venous abnormality
identified),
● incorporation of the date of classification and level of
investigation, and
● description of basic CEAP introduced as a simpler
alternative to the full (advanced) CEAP classification.
For the practicing physician, CEAP is an instrument for
correct diagnosis to guide treatment and assess prognosis.
For the researcher and reporting standards, CEAP aids to
group the patients so that we are looking at the same type of
patients. It is important to state that CEAP is a descriptive
classification and a base for diagnosis and prognosis,
whereas venous severity scoring and quality-of-life estima-
tion are instruments for longitudinal research to assess
outcomes. The new venous severity scoring system pro-
duced by the AVF ad hoc committee on outcomes under
the leadership of Robert Rutherford46 was intended to
complement the descriptive CEAP classification.
It is up to the AVF and its outcomes committee to
continue its important work to standardize the tests for
CVD. Quoting Robert Kistner from his presidential ad-
dress:
Until the use of the CEAP classification for completeness
of diagnosis and the employment of reliable tests to
accurately identify pathologic problems are in place, wewill not be able to conduct the large scale clinical studies
with the statistical power afforded by larger numbers that
will lead to sustainable conclusions about the relative
values of various treatment methods in clinical practice.21
In December last year, I attended an excellent consen-
sus meeting on Management of CVD of the Lower Limbs,
organized by Andrew Nicolaides on Cyprus. I was dis-
turbed by the repeated statement “the cornerstone for
management of CVD is compression therapy.” This is an
archaic, counterproductive, and defensive opinion. With all
the new armamentaria available to diagnose and treat CVD,
I would state that the “cornerstone for management of
CVD is an accurate diagnosis and classification of the
underlying venous problem, which creates the base for
correctly directed treatment.” Compression therapy is cer-
tainly one aspect of the treatment, but is not the corner-
stone anymore!
A spiritual reunion on the island of Ven. Robert
and Adelaide Kistner came to Tycho Brahe’s island of Ven
in 1982 as the international guest speaker for Societas
Phlebologica Scandinavica, the society that Gunnar Bauer
established in 1963, thereby creating a spiritual reunion
between the three pioneers and giants, Tycho Brahe, Gun-
nar Bauer, and Robert Kistner.
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